In addition, knockdown of KEAP1 inhibited autophagy and increased apoptosis, indicating that FXR1 promotes resistance by modulating the KEAP1–Nrf2 pathway; thus, FXR1 plays a key role in the resistance of ccRCC cells to axitinib [130]. Here, NFE2L2 is linked to nonpapillary renal cell carcinoma.